CollPlant: director's milestone warrants cover up to 4M
Milestone warrant exercisability is tied to three business milestones, with a separate share tranche for each milestone.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Ruty Ben Shlomi, a director of CollPlant Biotechnologies Ltd, reported direct holdings of 66,501 ordinary shares, 105,038 pre-funded warrants, and milestone pre-funded warrants covering up to 3,999,446 ordinary shares. Both warrant holdings list an exercise price of $0.0001. The reported security amounts were adjusted to reflect the 1-for-10 reverse stock split effective September 4, 2026; milestone warrant exercisability is subject to specified business milestones.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Pre-Funded Warrants to Purchase Ordinary Shares F2, F1 | -- | -- | -- |
| holding | Milestone Pre-Funded Warrants to Purchase Ordinary Shares F3, F1 | -- | -- | -- |
| holding | Ordinary Shares F1 | -- | -- | -- |
Footnotes (3)
- F1. Effective as of September 4, 2026, the Issuer effected a 1-for-10 reverse stock split of its Ordinary Shares (the "Reverse Stock Split"). The amount of securities reported on this Form 3 has been adjusted to reflect the Reverse Stock Split.
- F2. The Pre-Funded Warrants remain exercisable until fully exercised.
- F3. The Milestone Pre-Funded Warrants become exercisable upon their issuance, subject to the achievement of specified business milestones, and remain exercisable until fully exercised. The Milestone Pre-Funded Warrants are exercisable for up to an aggregate of 3,999,446 ordinary shares, no par value, of the Issuer (the "Ordinary Shares"), with the first tranche, covering 441,683 Ordinary Shares, becoming exercisable upon achievement of the first milestone; the second tranche, covering 1,718,726 Ordinary Shares, becoming exercisable upon achievement of the second milestone; and the third tranche, covering 1,839,037 Ordinary Shares, becoming exercisable upon achievement of the third milestone, in each case subject to the terms and conditions of the Milestone Pre-Funded Warrants.
Key Figures
Key Terms
Pre-Funded Warrants financial
Milestone Pre-Funded Warrants financial
tranche financial
Reverse Stock Split financial
Stock Split
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When can CLGN's milestone pre-funded warrants be exercised?
AI-generated analysis. How Rhea-AI works. Not financial advice.